<DOC>
	<DOCNO>NCT01186978</DOCNO>
	<brief_summary>This study evaluate whether reduction radiation dose field size maintain high rate local control minimize risk acute late toxicity . Hypothesis- The radiation dose treatment volume safely reduce 30 Gy 20 Gy maintain high rate local control patient negative PET scan follow rituximab-containing chemotherapy .</brief_summary>
	<brief_title>Reduced Radiation Patients With Diffuse Large B-cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<criteria>Histologic documentation diffuse large Bcell lymphoma , variant define WHO classification Completion least 4 cycle rituximabcontaining , anthracyclinebased combination chemotherapy Negative postchemotherapy ( interim ) PET scan Absolute neutrophil count great 1500 platelet count great 40,000 Negative pregnancy test woman childbearing potential For patient HIV/AIDS , follow must true : The patient compliant combination antiretroviral therapy ( CART ) The patient CD4 count â‰¥ 200 time diagnosis Any contraindication irradiation Primary CNS lymphoma HIV/AIDS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>